Thermo Fisher Scientific Inc. (TMO): Price and Financial Metrics
GET POWR RATINGS... FREE!
TMO POWR Grades
- Sentiment is the dimension where TMO ranks best; there it ranks ahead of 91.7% of US stocks.
- The strongest trend for TMO is in Growth, which has been heading down over the past 177 days.
- TMO ranks lowest in Momentum; there it ranks in the 10th percentile.
TMO Stock Summary
- TMO has a higher market value than 99.29% of US stocks; more precisely, its current market capitalization is $215,170,194,786.
- THERMO FISHER SCIENTIFIC INC's stock had its IPO on September 1, 1987, making it an older stock than 92.3% of US equities in our set.
- In terms of volatility of its share price, TMO is more volatile than just 3.66% of stocks we're observing.
- Stocks that are quantitatively similar to TMO, based on their financial statements, market capitalization, and price volatility, are SHEL, DHR, BABA, BAC, and NKE.
- Visit TMO's SEC page to see the company's official filings. To visit the company's web site, go to www.thermofisher.com.
TMO Valuation Summary
- TMO's price/earnings ratio is 31; this is 33.62% higher than that of the median Healthcare stock.
- Over the past 243 months, TMO's EV/EBIT ratio has gone up 20.
Below are key valuation metrics over time for TMO.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| TMO | 2023-03-24 | 4.8 | 4.9 | 31.0 | 28.8 |
| TMO | 2023-03-23 | 4.8 | 4.9 | 30.8 | 28.6 |
| TMO | 2023-03-22 | 4.8 | 4.9 | 30.7 | 28.6 |
| TMO | 2023-03-21 | 4.8 | 4.9 | 30.9 | 28.7 |
| TMO | 2023-03-20 | 4.7 | 4.8 | 30.5 | 28.4 |
| TMO | 2023-03-17 | 4.7 | 4.8 | 30.4 | 28.3 |
TMO Growth Metrics
- Its 4 year price growth rate is now at 92.8%.
- Its 5 year net income to common stockholders growth rate is now at 69%.
- The year over year price growth rate now stands at 16.7%.
The table below shows TMO's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 44,167 | 8,124 | 7,032 |
| 2022-06-30 | 42,820 | 8,837 | 7,439 |
| 2022-03-31 | 41,123 | 9,536 | 7,603 |
| 2021-12-31 | 39,211 | 9,312 | 7,725 |
| 2021-09-30 | 39,059 | 10,194 | 8,565 |
| 2021-06-30 | 38,250 | 10,252 | 8,596 |
TMO's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- TMO has a Quality Grade of C, ranking ahead of 62.66% of graded US stocks.
- TMO's asset turnover comes in at 0.574 -- ranking 43rd of 75 Measuring and Control Equipment stocks.
- PACB, PKI, and PRPO are the stocks whose asset turnover ratios are most correlated with TMO.
The table below shows TMO's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-07-03 | 0.574 | 0.513 | 0.323 |
| 2021-04-03 | 0.551 | 0.515 | 0.302 |
| 2020-12-31 | 0.509 | 0.497 | 0.244 |
| 2020-09-26 | 0.470 | 0.473 | 0.209 |
| 2020-06-27 | 0.446 | 0.454 | 0.166 |
| 2020-03-28 | 0.443 | 0.443 | 0.174 |
TMO Price Target
For more insight on analysts targets of TMO, see our TMO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $586.74 | Average Broker Recommendation | 1.36 (Strong Buy) |
TMO Stock Price Chart Interactive Chart >
TMO Price/Volume Stats
| Current price | $562.97 | 52-week high | $618.35 |
| Prev. close | $555.15 | 52-week low | $475.77 |
| Day low | $556.86 | Volume | 1,219,900 |
| Day high | $564.28 | Avg. volume | 1,424,674 |
| 50-day MA | $562.63 | Dividend yield | 0.25% |
| 200-day MA | $549.36 | Market Cap | 216.99B |
Thermo Fisher Scientific Inc. (TMO) Company Bio
Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues. (Source:Wikipedia)
Latest TMO News From Around the Web
Below are the latest news stories about THERMO FISHER SCIENTIFIC INC that investors may wish to consider to help them evaluate TMO as an investment opportunity.
Thermo Fisher (TMO) Opens New Cell Therapy Facility at UCSFThermo Fisher's (TMO) new cell therapy facility at UCSF is likely to accelerate the development of advanced therapies. |
Insiders at Thermo Fisher Scientific Inc. (NYSE:TMO) sold US$1.3m worth of stock, possibly indicating weakness in the futureOver the past year, many Thermo Fisher Scientific Inc. ( NYSE:TMO ) insiders sold a significant stake in the company... |
The Zacks Analyst Blog Highlights Berkshire Hathaway, Roche Holding, Thermo Fisher Scientific, Mitsubishi UFJ Financial Group and SynopsysBerkshire Hathaway, Roche Holding, Thermo Fisher Scientific, Mitsubishi UFJ Financial Group and Synopsys are included in this Analyst Blog. |
‘The End of the Bear Market May Be in Sight,’ Says Morgan Stanley. Here Are 3 Stocks the Banking Giant Likes for Long-Term GrowthThis year started with a strong rally in the markets, but the past month has seen the positive sentiments start to sputter. The failure of Silicon Valley Bank started fears of a contagion and consequent bank runs, which were only partially offset by Federal regulatory actions. But there’s a growing consensus that it was the Federal actions that set the conditions for the bank crisis, when the central bank raised interest rates to fight inflation. Now, investors are trying to cope with the fallou |
Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco, to Accelerate Development of Breakthrough TherapiesWALTHAM, Mass. & SAN FRANCISCO, March 27, 2023--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult to treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP manufacturing facility adjacent to UCSF Medical Center’s Mission Bay campus. |
TMO Price Returns
| 1-mo | 4.61% |
| 3-mo | 2.30% |
| 6-mo | 11.13% |
| 1-year | -4.47% |
| 3-year | 99.80% |
| 5-year | 175.99% |
| YTD | 2.30% |
| 2022 | -17.29% |
| 2021 | 43.54% |
| 2020 | 43.72% |
| 2019 | 45.55% |
| 2018 | 18.21% |
TMO Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Continue Researching TMO
Want to do more research on Thermo Fisher Scientific Inc's stock and its price? Try the links below:Thermo Fisher Scientific Inc (TMO) Stock Price | Nasdaq
Thermo Fisher Scientific Inc (TMO) Stock Quote, History and News - Yahoo Finance
Thermo Fisher Scientific Inc (TMO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...